50
Participants
Start Date
March 14, 2022
Primary Completion Date
September 5, 2025
Study Completion Date
September 5, 2027
Ipilimumab + nivolumab
"Induction with immune checkpoint blockade: ipilimumab 3mg/kg on day 1, pilimumab 3mg/kg plus nivolumab 1mg/kg on day 22, and nivolumab 3mg/kg on day 43~Response evaluation after the last cycle of checkpoint inhibition.~Chemoradiation will start 10-12 weeks after start of checkpoint inhibition according to the following scheme:~* Mitoycine C (12mg/m2) on the first day of radiotherapy, followed by either 5-fluorouracil intravenously (500mg/m2) five days a week during week one and four of radiation, or oral capecitabin (2x825mg/m2) every day during the radiation period~* Radiation with a preference for a four-week schedule, in which 55 Gy will be administered using intensity modulated radiation therapy"
Antoni van Leeuwenhoek ziekenhuis, Amsterdam
Erasmus Medical Center, Rotterdam
Universitair Medisch Centrum Utrecht, Utrecht
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
The Netherlands Cancer Institute
OTHER